Filter News
Area of Research
- (-) Biology and Soft Matter (1)
- (-) Nuclear Science and Technology (4)
- Advanced Manufacturing (4)
- Biological Systems (2)
- Biology and Environment (133)
- Clean Energy (157)
- Climate and Environmental Systems (5)
- Computational Biology (2)
- Computational Engineering (3)
- Computer Science (7)
- Electricity and Smart Grid (1)
- Energy Sciences (1)
- Functional Materials for Energy (2)
- Fusion and Fission (7)
- Fusion Energy (1)
- Isotopes (7)
- Materials (65)
- Materials for Computing (7)
- Mathematics (1)
- National Security (16)
- Neutron Science (29)
- Quantum information Science (1)
- Supercomputing (82)
News Topics
- (-) Bioenergy (1)
- (-) Biomedical (2)
- (-) Environment (2)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (11)
- Chemical Sciences (1)
- Climate Change (1)
- Computer Science (2)
- Coronavirus (1)
- Cybersecurity (1)
- Decarbonization (2)
- Fusion (8)
- Isotopes (5)
- Materials Science (3)
- Molten Salt (4)
- Neutron Science (5)
- Nuclear Energy (36)
- Physics (2)
- Space Exploration (5)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
ORNL biogeochemist Elizabeth Herndon is working with colleagues to investigate a piece of the puzzle that has received little attention thus far: the role of manganese in the carbon cycle.
The combination of bioenergy with carbon capture and storage could cost-effectively sequester hundreds of millions of metric tons per year of carbon dioxide in the United States, making it a competitive solution for carbon management, according to a new analysis by ORNL scientists.
The Department of Energy’s Office of Science has selected three Oak Ridge National Laboratory scientists for Early Career Research Program awards.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.